Abstract
We tested the hypothesis that prior inhibition of spontaneous GH secretion by administration of the somatostatin analog SMS 201-995 (SMS) will enhance the GH response to a subsequent GRF challenge. Two controlled protocols were employed in 37 short children [M=31, F=6, aged 11.8 ± 1.6 yr (M ± SEM), height SDS −2.25 ± 0.55]. Study I determined an optimal regimen: SMS (0.8-2.2 ug/kg, sc) was randomly administered or not at 08:00 h and a GRF bolus (50 ug, iv) was given 4 h later. Study 2 used standard doses of SMS (1 ug/kg, sc) and GRF (1 ug/kg, iv), and a 1 h delay of the GRF injection. GH levels were measured q 20 min until 2 h following the GRF and expressed as the GH area under the curve during the 4-5 h SMS-GRF interval (AUC 1, ug/L/h) and as GH response to GRF for 2 h following GRF (AUC 2, ug/L/h; GH peak, ug/L).
In study 1, SMS significantly suppressed spontaneous GH secretion and GH response to GRF, compared to control. In study 2, GH secretion was still suppressed during the 5-h SMS-GRF interval, but both the GH area and peak GH response to GRF were significantly increased by pretreatment with SMS. Thus, a “priming” SMS dose of 1 ug/kg significantly augmented the GH response to GRF given 5 h later, enhancing the diagnostic value of the 'standard” GRF test.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dickerman, Z., Guyda, H. & Tannenbaum, G. PRETREATMENT WITH SMS 201–995 POTENTIATES GRF RESPONSE IN SHORT CHILDREN. Pediatr Res 33 (Suppl 5), S60 (1993). https://doi.org/10.1203/00006450-199305001-00343
Issue date:
DOI: https://doi.org/10.1203/00006450-199305001-00343
